From growth hormone-releasing peptides to ghrelin: Discovery of new modulators of GH secretion

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 1, 2006, Pages 17-24

  Lengyel, Ana Maria J ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

GH; Ghrelin; GHS; Growth hormone secretagogues

Indexed keywords

EID: 33646716838     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302006000100004     Document Type: Review

References (61)

1. Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984;114:1537-45.
2. Smith RG, Van der Ploeg LHT, Howard AD, et al. Peptidomimetic regulation of growth hormone secretion. Endocr Rev 1997;18:621-45.
3. Korbonits M, Grossman A. Growth hormone-releasing peptide and its analogues - novel stimuli to growth hormone release. Trends Endocrinol Metab 1995;6:43-9.
4. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273:947-77.
5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60.
6. Arvat E, DiVito L, Broglio F, Papotti M, Muccioli G, Dieguez C, et al. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000;23:493-5.
7. Korbonits M, Goldstone A P, Gueorguiev M, Grossman AB. Ghrelin - a hormone with multiple functions. Front Neuroendocrinol 2004;25:27-68.
8. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004;25:426-57.
9. Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004;101:4679-84.
10. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002;87:2988-91.
11. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, et al. Plasma ghrelin levels after dietinduced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623-30.
12. Banks WA, Tschop M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002;302:822-7.
13. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000;85:4908-11.
14. Arvat E, Maccario M, DiVito L, Broglio F, Benso A, Gottero C, et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001;86:1169-74.
15. Peñalva A, Carballo A, Pombo M, Casanueva F, Dieguez C. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. J Clin Endocrinol Metab 1993;76:168-71.
16. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, et al. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001;86:4552-5.
17. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 1995;80:942-7.
18. Popovic V, Miljic D, Micic D, Damjanovic S, Arvat E, Ghigo E, et al. Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. J Clin Endocrinol Metab 2003;88:3450-3.
19. Tannenbaum GS, Bowers CY. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin. Endocrine 2001;14:21-7.
20. Pandya N, Mott-Friberg R, Bowers CY, Barkan AL, Jaffe CA. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J Clin Endocrinol Metab 1998;83:1186-9.
21. Dickson SL, Doutrelant-Viltart O, Leng G. GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6. J Endocrinol 1995;146:519-26.
22. Maheshwari H, Rahim A, Rahim A, Shalet S, Baumann G. Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GHreleasing hormone receptor deficiency. J Clin Endocrinol Metab 1999;84:956-9.
23. Wren AM, Small CJ, Fribbens CV, Neary NM, Ward HL, Seal LJ, et al. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 2002;76:316-24.
24. Korbonits M, Little JA, Forsling ML, Tringali G, Costa A, Navarra P, et al. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol 1999;11:521-8.
25. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M, et al. Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 1994;135:1073-6.
26. Goth MI, Lyons CE, Canny BJ, Thorner MO. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptor. Endocrinology 1992;130:939-44.
27. Malagon MM, Luque RM, Ruiz-Guerrero E, Rodriguez-Pacheco F, Garcia-Navarro S, Casanueva FF, et al. Intracellular signaling mechanisms mediating ghrelinstimulated growth hormone release in somatotropes. Endocrinology 2003;144:5372-80.
28. Tolle V, Bassant MH, Zizzari P, Poindessous-Jazat F, Tomasetto C, Epelbaum J, et al. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 2002;143:1353-61.
29. Okimura Y, Ukai K, Hosoda H, Murata M, Iguchi G, Iida K, et al. The role of circulating ghrelin in growth hormone (GH) secretion in freely moving male rats. Life Sci 2003;72:2517-24.
30. Tannenbaum GS, Epelbaum J, Bowers CY. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 2003;144:967-74.
31. Barkan AL, Dimaraki EV, Jessup SK, Symons KV, Ermolenko M, Jaffe CA. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 2003;88:2180-4.
32. Halem HA, Taylor JE, Dong JZ, Shen Y, Datta R, Abizaid A, et al. Novel analogs of ghrelin: physiological and clinical implications. Eur J Endocrinol 2004;151 (suppl. 1):S71-5.
33. Zizzari P, Halem H, Taylor J, Dong JZ, DattaR, Culler MD, et al. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology 2005;146:3836-42.
34. Tannenbaum GS, Samia M, Chen Q, Bowers CY. Antagonism of the growth hormone secretagogue receptor unmasks a role for ghrelin in maintaining high GH pulse amplitude under physiological conditions. Endo Soc 87th Ann Meet 2005; San Diego, USA, June 4-7.
35. Pantel J, Cabrol S, Nivot S. Familial short stature associated with a mutation in the growth hormone secretagogue receptor (GHSR). Endo Soc 86th Ann Meet 2004; New Orleans, USA, June 16-19.
36. Koutkia P, Canavan B, Breu J, Johnson ML, Grinspoon SK. Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men. Am J Physiol Endocrinol Metab 2004;287:E506-12.
37. Kamegai J, Tamura H, Shimizu T, Ishii S, Tatsuguchi A, Sugihara H, et al. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content. Endocrinology 2004;145:3731-8.
38. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 2003;23:7973-81.
39. Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 2002;109:1429-36.
40. Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004;101:4679-84.
41. Peino R, Baldelli R, Rodriguez-Garcia J, Rodriguez-Segade S, Kojima M, et al. Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol 2000;143:R11-4.
42. Popovic V, Leal A, Micic D, Koppeschaar HPF, Torres E, Paramo C, et al. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 2000;356:1137-42.
43. Broglio F, Benso A, Castiglioni C, Gottero C, Prodam F, Destefanis S, et al. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 2003;88:1537-42.
44. Cordido F, Peñalva A, Dieguez C, Casanueva FF. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 1993;76:819-23.
45. Tassone F, Broglio F, Destefanis S, Rovere S, Benso A, Gottero C, et al. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab 2003;88:5478-83.
46. Maccario M, Arvat E, Procopio M, Gianotti L, Grottoli S, Imbimbo BP, et al. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metabolism 1995;44:134-8.
47. DiVito L, Broglio F, Benso A, Gottero C, Prodam F, Papotti M, et al. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin Endocrinol 2002;56:643-8.
48. Broglio F, Benso A, Gottero C, Prodam F, Grottoli S, Tassone F, et al. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol 2002;57:265-71.
49. Maier C, Schaller G, Buranyi B, Nowotny P, Geyer G, Wolzt M, et al. The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. J Clin Endocrinol Metab 2004;89:4729-33.
50. Gertz BJ, Sciberras DG, Yogendran L, Christie K, Bador K, Krupa D, et al. L-692,429, a nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion. J Clin Endocrinol Metab 1994;79:745-9.
51. Arvat E, DiVito L, Gianotti L, et al. Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. Metabolism 1997;46:83-8.
52. Leal-Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clin Endocrinol 1994;41:649-54.
53. Borges MH, DiNinno FB, Lengyel AM. Different effects of growth hormone releasing peptide (GHRP-6) and GHreleasing hormone on GH release in endogenous and exogenous hypercortisolism. Clin Endocrinol 1997;46:713-8.
54. Leal-Cerro A, Torres E, Soto A, Dios E, Deghenghi R, Arvat E, et al. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses. Neuroendocrinology 2002;76:390-6.
55. Correa-Silva SR, Nascif SO, Silva MR, Senger MH, Miranda WL, Machado AF, et al. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GHRP-6. Proc 12th Intern Congr Endocrinol 2004. Lisbon, Portugal, August 31- September 4.
56. Arvat E, Giordano R, Ramunni J, Arnaldi G, Colao A, Deghenghi R, et al. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma. J Clin Endocrinol Metab 1998;83:4207-11.
57. Pinto AC, Silva MR, Martins MR, Brunner E, Lengyel AM. Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing peptide-6: studies in normal men and in patients with adrenal insufficiency. J Clin Endocrinol Metab 2000;85:1540-4.
58. Ramos-Dias JC, Pimentel-Filho F, Reis AF, Lengyel AM. Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidism. J Clin Endocrinol Metab 1996;81:1343-6.
59. Nascif SO, Correa-Silva S, Silva MR, Senger MH, Lengyel AM. The effects of ghrelin on GH, ACTH and cortisol release in thyrotoxicosis. Proc 12th Intern Congr Endocrinol 2004. Lisbon, Portugal, August 31-September 4.
60. Weffort RFVB, Ramos-Dias JC, Chipoch C, Lengyel AM. Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus. Metabolism 1997;46:706-10.
61. Broglio F, Gianotti L, Destefanis S, et al. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol 2004;60:592-9.